These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


329 related items for PubMed ID: 15192792

  • 21. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?
    Heimbach JK, Gores GJ, Nagorney DM, Rosen CB.
    Surgery; 2006 Sep; 140(3):331-4. PubMed ID: 16934588
    [No Abstract] [Full Text] [Related]

  • 22. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
    Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Nozawa S.
    Surgery; 2007 May; 141(5):581-8. PubMed ID: 17462457
    [Abstract] [Full Text] [Related]

  • 23. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T.
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [Abstract] [Full Text] [Related]

  • 24. Liver transplantation for cholangiocarcinoma.
    Rosen CB, Heimbach JK, Gores GJ.
    Transpl Int; 2010 Jul; 23(7):692-7. PubMed ID: 20497401
    [Abstract] [Full Text] [Related]

  • 25. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
    Golfieri R, Giampalma E, Renzulli M, Galuppi A, Vicenzi L, Galaverni MC, Cappelli A.
    In Vivo; 2006 Jul; 20(6A):757-60. PubMed ID: 17203762
    [Abstract] [Full Text] [Related]

  • 26. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.
    Cancer J; 2006 Jul; 12(2):113-22. PubMed ID: 16630402
    [Abstract] [Full Text] [Related]

  • 27. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
    Panjala C, Nguyen JH, Al-Hajjaj AN, Rosser BA, Nakhleh RE, Bridges MD, Ko SJ, Buskirk SJ, Kim GP, Harnois DM.
    Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
    [Abstract] [Full Text] [Related]

  • 28. Role of liver transplantation in the treatment of cholangiocarcinoma.
    Singal A, Welling TH, Marrero JA.
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):491-502. PubMed ID: 19374602
    [Abstract] [Full Text] [Related]

  • 29. [Combined total hepatectomy, orthotopic liver transplantation and pancreatoduodenectomy for unresectable hilar bile duct carcinoma].
    He XS, Zhang S, Zhu XF, Ji Y, Zeng JX, Ma Y, Wang DP, Ju WQ, Wu LW, Li Z, Huang JF.
    Zhonghua Wai Ke Za Zhi; 2006 Mar 01; 44(5):302-5. PubMed ID: 16635386
    [Abstract] [Full Text] [Related]

  • 30. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy.
    Serafini FM, Sachs D, Bloomston M, Carey LC, Karl RC, Murr MM, Rosemurgy AS.
    Am Surg; 2001 Sep 01; 67(9):839-43; discussion 843-4. PubMed ID: 11565760
    [Abstract] [Full Text] [Related]

  • 31. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, Newman SB, Benson A, Omary RA, Salem R.
    Cancer; 2008 Oct 15; 113(8):2119-28. PubMed ID: 18759346
    [Abstract] [Full Text] [Related]

  • 32. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.
    Ghali P, Marotta PJ, Yoshida EM, Bain VG, Marleau D, Peltekian K, Metrakos P, Deschênes M.
    Liver Transpl; 2005 Nov 15; 11(11):1412-6. PubMed ID: 16237695
    [Abstract] [Full Text] [Related]

  • 33. Brachytherapy in the treatment of cholangiocarcinoma.
    Shinohara ET, Guo M, Mitra N, Metz JM.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):722-8. PubMed ID: 20207503
    [Abstract] [Full Text] [Related]

  • 34. [Experience of surgical resection of 103 hilar cholangiocarcinoma].
    Liang LJ, Lai JM, Li SQ, Peng BG, Yin XY, Tang D, Lü MD, Huang JF.
    Zhonghua Wai Ke Za Zhi; 2006 Jul 01; 44(13):882-4. PubMed ID: 17067476
    [Abstract] [Full Text] [Related]

  • 35. [Retrospective analysis of 47 cases with hilar cholangiocarcinoma using T-staging system].
    Peng CH, Zhao ZM, Peng SY, Liu YB, Wu YL, Fang HQ, Jiang XC.
    Zhonghua Wai Ke Za Zhi; 2005 Jan 01; 43(1):56-9. PubMed ID: 15774176
    [Abstract] [Full Text] [Related]

  • 36. Transplantation for hilar cholangiocarcinoma.
    Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, Gores GJ.
    Liver Transpl; 2004 Oct 01; 10(10 Suppl 2):S65-8. PubMed ID: 15382214
    [Abstract] [Full Text] [Related]

  • 37. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K.
    Hepatogastroenterology; 2007 Mar 01; 54(74):346-9. PubMed ID: 17523271
    [Abstract] [Full Text] [Related]

  • 38. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A, Maréchal R, Devière J, Van Laethem JL.
    Best Pract Res Clin Gastroenterol; 2007 Mar 01; 21(6):1015-29. PubMed ID: 18070701
    [Abstract] [Full Text] [Related]

  • 39. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K.
    Cancer; 2005 Mar 15; 103(6):1210-6. PubMed ID: 15685618
    [Abstract] [Full Text] [Related]

  • 40. Transplantation for cholangiocarcinoma: Advance or supply-demand dilemma?
    Callery MP.
    Gastroenterology; 2006 Jun 15; 130(7):2242-4; discussion 2244. PubMed ID: 16762651
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.